About Leeaf
Leeaf was launched in 2020 with a mission to transform fertility care through innovative technology. Since then, we’ve expanded our reach, growing into a company determined to provide women with comprehensive guidance, education, and care across the entire spectrum of their reproductive health. Our platform supports women, regardless of the journey they are on, with the tools and knowledge necessary to make informed decisions, bridging the gender gap in healthcare with an accessible and thoughtfully designed solution.
Mission
Our mission is to empower women by offering personalized support for all their reproductive health needs—whether it's tracking periods, managing conditions, planning a pregnancy, or accessing preventive care.
Vision
We envision a future where women feel informed, supported, and confident in managing their reproductive health. With Leeaf, we aim to reduce risks, provide access to vital information, and ensure women know their options at every stage of their reproductive journey.
Founder's Story
Read our Founder's Story on our blog to find out what motivated our founder
and how Leeaf came to life.
Read Leeaf Founder's Story ->and how Leeaf came to life.
Management team
Olga Chabr Grillova
CEO
Lucie Borovickova
Head of Data Science
Bohuslav Lichnovsky
Head of Legal and Data Protection
Scientific Board
Associate Prof. Rita Vassena, DVM, PhD.
Clínica EUGIN (ES)
Prof. Gabor L. Kovacs, M.D.
Chairman of the Leeaf Scientific Board
Szentagothai Research Center University of Pecs (HU)
Prof. Ivana Oborna, PhD.
Fetmed (CZ)
Assoc. Prof. Glenn L. Schattman, M.D.
Weill Cornell Medicine (US)
Dr. Nabil Aziz, M.D.
Spire Liverpool Hospital (UK)
Dr. Francisco Anaya Blanes, M.D.
UR La Vega Alicante (ES)
Research
At Leeaf, we strive to innovate through science utilizing modern technology transparently and ethically.
Our research contributes to the field of artificial reproduction through dedicated research projects as well as independent, standardized, and anonymized data collection.
To contribute to the improvement of fertility treatment outcomes on a larger scale, the Leeaf research team is currently conducting a study to verify the effectiveness of data and AI-driven treatment personalization in increasing pregnancy and take-home baby rates for infertile couples.
Simultaneously, our continuous data collection seeks to reveal how lifestyle changes initiated and tracked through women‘s lifestyle wearables impact IVF results.
Our research contributes to the field of artificial reproduction through dedicated research projects as well as independent, standardized, and anonymized data collection.
To contribute to the improvement of fertility treatment outcomes on a larger scale, the Leeaf research team is currently conducting a study to verify the effectiveness of data and AI-driven treatment personalization in increasing pregnancy and take-home baby rates for infertile couples.
Simultaneously, our continuous data collection seeks to reveal how lifestyle changes initiated and tracked through women‘s lifestyle wearables impact IVF results.
Principles of Ethical AI
Leeaf’s Ethical AI Principles are based on the latest thought leadership of global technology and consulting companies. We acknowledge that algorithms augment the capabilities of doctors to produce better results,
together. Final decision making stays with the patient and should always be based on doctors' treatment
guidance and approval. The data provided always belongs to the patient, with algorithms and technology
remaining transparent, explainable, fair, and auditable at any time.
together. Final decision making stays with the patient and should always be based on doctors' treatment
guidance and approval. The data provided always belongs to the patient, with algorithms and technology
remaining transparent, explainable, fair, and auditable at any time.